Molecular marker for diagnosis of diabetes and application thereof

Abstract

The invention belongs to the technical field of biology, and particularly to a molecular marker for diagnosis of diabetes and application thereof. For the problem that currently, no reliable biomarkercan perform risk prediction and early diagnosis on the diabetes, the following solution is proposed that the molecular marker comprises a kit and diagnostic primers, wherein the kit is internally provided with a chip, the chip comprises a gene chip, a gene primer and a molecular marker, the diagnostic primers comprise the forward primer and the reverse primer, and the forward primer and the reverse primer are both set to have RNA molecule sequences. Trough the detection of items related to a thrombus molecular marker, not only is further knowing of complications of DM vascular injuries and the pathogenesis of thrombosis facilitated, but also a basis is provided for using anticoagulant antiplatelet drugs for treatment, and the detection of molecules of type 2 diabetes patients has important clinical significance for the early prevention or intervention of thrombogenesis and vasculopathy.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a molecular marker for diabetes diagnosis and its application. Background technique [0002] Diabetes mellitus is a metabolic disorder characterized by high and chronic blood glucose (referred to as blood sugar) levels caused by absolute or relative lack of insulin. It is one of the most important non-communicable diseases currently threatening global human health. According to statistics from the Union, the number of diabetic patients in the world has reached 370 million in 2011, 80% of which are in developing countries. It is estimated that there will be nearly 550 million diabetic patients in the world by 2030. In 2011, a total of 4.6 million people died of diabetes worldwide, and the global medical cost of diabetes reached 465 billion US dollars in that year. Among them, the rapid growth of diabetes in China and other developing countries has brought a heavy burden to the social...

AI Technical Summary

Problems solved by technology

[0005] At present, the diagnosis of diabetes mainly relies on clinical examination and various auxiliary technologies. Although medical technology has been highly developed compared with the past, there are still no reliable biomarkers in clinical practice for risk prediction and early diagnosis of diabetes.